missing translation for 'onlineSavingsMsg'
Learn More
Learn More
DiscoverX PathHunter™ U2OS LCK Activity Assay
Descrizione
The PathHunter™ U2OS LCK Activity Assay is a stable, engineered cell line for use in studying small molecule drug candidates targeting CTKs. This cell line enables assessment of CTK activation via detection of resulting GHR phosphorylation-induced SH2 domain protein recruitment, mediated by LCK-JAK2 fusion protein. This product uses EFC technology. The included cell line overexpresses PK-tagged relevant cytokine receptor and EA-tagged SH2 domain protein alongside an engineered fusion of the cytokine receptor binding domain of JAK2 (Janus Kinase 2) to the catalytic domain from the CTK of interest, LCK. Upon activation of the cytokine receptor, the CRBD-CTK fusion phosphorylates the receptor, leading to SH2-EA recruitment and production of EFC signal. This stable modified cell line is provided as two vials of cryopreserved cells.
Specifica
Specifica
| Assay Entry | SH2 Recruitment |
| Linea cellulare | U2OS |
| Da utilizzare con (applicazione) | Cell Lines |
| Primary Agonist | Recombinant Human Growth Hormone |
| Quantità | 2 Vials |
| Target Entry | LCK |
| Numero di accesso | NM_000163 |
Titolo del prodotto
Facendo clic su Invia, l'utente riconosce che potrebbe essere contattato da Fisher Scientific in merito al feedback fornito in questo modulo. Non condivideremo le vostre informazioni per altri scopi. Tutte le informazioni di contatto fornite saranno conservate in conformità con la nostra Politica sulla privacy. Informativa sulla privacy.
Individuate un'opportunità di miglioramento?